Exact Mass: 297.10597640000003
Exact Mass Matches: 297.10597640000003
Found 202 metabolites which its exact mass value is equals to given mass value 297.10597640000003
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Musk xylene
Flavouring compound [Superscent]
2-Methylguanosine
C11H15N5O5 (297.10731400000003)
2-Methylguanosine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 17336316, 17154124, 3506820, 17044778, 17264127) [HMDB] 2-Methylguanosine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 17336316, 17154124, 3506820, 17044778, 17264127). N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's. N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's.
1-Methylguanosine
C11H15N5O5 (297.10731400000003)
1-Methylguanosine is a methylated nucleoside. It is known that some modified, especially methylated, nucleosides originating from RNA degradation are excreted in abnormal levels in the urine of patients with malignant tumours. These nucleosides have been proposed as tumour markers. Their measurement could provide a non-invasive diagnostic method, help identify different cancers, and monitor any therapeutic effects (PMID:9129323). 1-Methylguanosine is a methylated nucleoside. It is known that some modified, especially methylated, nucleosides originating from RNA degradation are excreted in abnormal levels in the urine of patients with malignant tumours and they have been proposed as tumour markers. Their 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1]. 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1].
3'-O-Methylguanosine
C11H15N5O5 (297.10731400000003)
3-O-Methylguanosine is an endogenous methylated nucleoside found in human fluids. Methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls. DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, it becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 3506820, 17044778, 17264127, 16799933) [HMDB] 3-O-Methylguanosine is an endogenous methylated nucleoside found in human fluids. Methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls. DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, it becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 3506820, 17044778, 17264127, 16799933). 3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-methylguanosine can inhibit early virus-specific RNA synthesis[1].
(S)-Annocherine A
(R)-Annocherine A is found in fruits. (R)-Annocherine A is an alkaloid from the leaves of Annona cherimola (cherimoya).
Nelarabine
C11H15N5O5 (297.10731400000003)
Nelarabine is only found in individuals that have used or taken this drug. It is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. Nelarabine is a purine nucleoside analog converted to its corresponding arabinosylguanine nucleotide triphosphate (araGTP), resulting in inhibition of DNA synthesis and cytotoxicity.Once nelarabine is metabolized into ara-GTP, the metabolite accumulates in leukemic blasts and incorporates into DNA to exert its S phase-specific cytotoxic effects, leading to the induction of fragmentation and apoptosis. Ara-GTP competes with endogenous deoxyGTP (dGTP) for incorporation into DNA. Once ara-GTP is incorporated at the 3 end of DNA, further DNA elongation is inhibited, which signals apoptosis and leads to cellular destruction. Additional cytotoxic activities may exist, but these are not fully understood. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Nelarabine (506U78) is a nucleoside analogue and can be used for the research of T cell acute lymphoblastic leukemia (T-ALL)[1].
2'-C-Methylguanosine
C11H15N5O5 (297.10731400000003)
Calcium diglutamate
Flavour enhancer; salt substitute. Calcium diglutamate, sometimes abbreviated CDG and also called calcium glutamate, is a compound with formula Ca(C5H8NO4)2. It is a calcium acid salt of glutamic acid. CDG is a flavor enhancer (E number E623) ? it is the calcium analog of monosodium glutamate (MSG). Because the glutamate is the actual flavor-enahancer, DCG has the same flavor-enhancing properties as MSG, but without the increased sodium content. As a soluble source of calcium ions, this chemical is also used as a first-aid treatment for exposure to hydrofluoric acid. Flavour enhancer; salt substitute
Fe(II)-nicotianamine
Fe(ii)-nicotianamine is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Fe(ii)-nicotianamine can be found in a number of food items such as chanterelle, amaranth, bitter gourd, and brazil nut, which makes fe(ii)-nicotianamine a potential biomarker for the consumption of these food products.
2-O-methylguanosine
C11H15N5O5 (297.10731400000003)
Guanosine with the hydrogen on the hydroxyl at position C-2 substituted with a methyl group. CONFIDENCE standard compound; INTERNAL_ID 318 2'-O-Methylguanosine is a modified nucleoside produced in tRNAs by the action of tRNA guanosine-2’-O-methyltransferase. 2'-O-Methylguanosine results in apoptotic changes of cells[1][2].
Triglycidyl isocyanurate
D000970 - Antineoplastic Agents Triglycidyl isocyanurate (TGIC; Teroxirone) is a triazene triepoxide with antiangiogenic and antineoplastic activities. Triglycidyl isocyanurate inhibits the growth of non-small-cell-lung cancer cells via?p53 activation. Triglycidyl isocyanurate induces cell apoptosis. Triglycidyl isocyanurate can be used for cancer research[1][2].
Ethyl 2-cyano-3-[(6-methoxy-8-quinolyl)amino]acrylate
7-Methylguanosine
C11H15N5O5 (297.10731400000003)
4xi-hydroxy-(1rC2)-spiro[cyclohexane-1,1-cyclopenta[ij][1,3]dioxolo[4,5-g]isoquinolin]-2-one|scortechiniine B
Nelarabine
C11H15N5O5 (297.10731400000003)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Nelarabine (506U78) is a nucleoside analogue and can be used for the research of T cell acute lymphoblastic leukemia (T-ALL)[1].
1-methylguanosine
C11H15N5O5 (297.10731400000003)
Guanosine substituted with a methyl group at position N-1. 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1]. 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1].
3-O-Methylguanosine
C11H15N5O5 (297.10731400000003)
Guanosine with the hydrogen on the hydroxyl at position C-3 substituted with a methyl group. 3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-methylguanosine can inhibit early virus-specific RNA synthesis[1].
N-Methylguanosine
C11H15N5O5 (297.10731400000003)
CONFIDENCE standard compound; INTERNAL_ID 319 N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's. N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's.
7-Methylguanosine; AIF; CE0; CorrDec
C11H15N5O5 (297.10731400000003)
7-Methylguanosine; AIF; CE10; CorrDec
C11H15N5O5 (297.10731400000003)
7-Methylguanosine; AIF; CE30; CorrDec
C11H15N5O5 (297.10731400000003)
7-Methylguanosine; AIF; CE0; MS2Dec
C11H15N5O5 (297.10731400000003)
7-Methylguanosine; AIF; CE10; MS2Dec
C11H15N5O5 (297.10731400000003)
7-Methylguanosine; AIF; CE30; MS2Dec
C11H15N5O5 (297.10731400000003)
N2-Methylguanosine; AIF; CE0; CorrDec
C11H15N5O5 (297.10731400000003)
N2-Methylguanosine; AIF; CE10; CorrDec
C11H15N5O5 (297.10731400000003)
N2-Methylguanosine; AIF; CE30; CorrDec
C11H15N5O5 (297.10731400000003)
N2-Methylguanosine; AIF; CE0; MS2Dec
C11H15N5O5 (297.10731400000003)
N2-Methylguanosine; AIF; CE10; MS2Dec
C11H15N5O5 (297.10731400000003)
N2-Methylguanosine; AIF; CE30; MS2Dec
C11H15N5O5 (297.10731400000003)
N1-Methylguanosine; AIF; CE0; CorrDec
C11H15N5O5 (297.10731400000003)
N1-Methylguanosine; AIF; CE10; CorrDec
C11H15N5O5 (297.10731400000003)
N1-Methylguanosine; AIF; CE30; CorrDec
C11H15N5O5 (297.10731400000003)
N1-Methylguanosine; AIF; CE0; MS2Dec
C11H15N5O5 (297.10731400000003)
N1-Methylguanosine; AIF; CE10; MS2Dec
C11H15N5O5 (297.10731400000003)
N1-Methylguanosine; AIF; CE30; MS2Dec
C11H15N5O5 (297.10731400000003)
Mebendazole metabolite (Carbamic acid, [5-(hydroxyphenylmethyl)-1H-benzimidazol-2-yl]-, methyl ester
3-OMG
C11H15N5O5 (297.10731400000003)
3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-methylguanosine can inhibit early virus-specific RNA synthesis[1].
5-OXO-1-(4-PHENOXYPHENYL)PYRROLIDINE-3-CARBOXYLICACID
4-{3-[3-(Trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}piperidine
TRANS-TERT-BUTYL 3-FLUORO-4-(METHYLSULFONYLOXY)PIPERIDINE-1-CARBOXYLATE
CIS-TERT-BUTYL 3-FLUORO-4-(METHYLSULFONYLOXY)PIPERIDINE-1-CARBOXYLATE
Methyl N-[(benzyloxy)carbonyl]-L-methioninate
C14H19NO4S (297.10347340000004)
2-tert-Butoxycarbonylamino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid
C14H19NO4S (297.10347340000004)
2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile
(R)-TERT-BUTYL (4-CHLORO-3-OXO-1-PHENYLBUTAN-2-YL)CARBAMATE
Ethyl 1-benzyl-5-hydroxy-1,2,3,6-tetrahydro-4-pyridinecarboxylate hydrochloride (1:1)
(S)2,3-DIHYDRO-INDOLE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER
1-(MESITYLSULFONYL)PYRROLIDINE-2-CARBOXYLIC ACID
C14H19NO4S (297.10347340000004)
1H-Indole-2-carboxylicacid, 5-methoxy-6-(phenylmethoxy)-
4-(toluene-4-sulfonylamino)-cyclohexanecarboxylic acid
C14H19NO4S (297.10347340000004)
1-phenylmethoxycarbonyl-2,3-dihydroindole-2-carboxylic acid
Ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride
8-acetyl-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one
3-METHYL-5-METHOXYCARBONYL-1-BENZYL-4-PIPERIDONE HYDROCHLORIDE
2-isonicotinoyl-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one
Ethyl 4-(4-aminophenoxy)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate
2H-3-Benzazepin-2-one, 3-(3-chloropropyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-
5-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-pyridinamine
1-[[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methylpyrrolidinium inner salt
C13H19N3O3S (297.11470640000005)
n-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1h-purin-2-yl]acetamide
C11H15N5O5 (297.10731400000003)
Methapyrilene Hydrochloride
C14H20ClN3S (297.10663900000003)
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Ethyl 1-benzyl-4-oxo-3-piperidinecarboxylate hydrochloride
Tritiozine
C14H19NO4S (297.10347340000004)
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent Trithiozine is an orally active antisecretory and antiulcer agent. Trithiozine can be used for the research of peptic ulcer disease and hypersecretory disorders[1].
8-(2R)-Oxiranyl-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one
(2Z)-5,6-Dimethoxy-2-[(1-oxido-4-pyridinyl)methylene]-1-indanone
Toluene-4-sulfonic acid (S)-1-acetyl-pyrrolidin-2-ylMethyl ester
C14H19NO4S (297.10347340000004)
(2-benzylidene-3-oxo-benzofuran-6-yl) acetate
C12H16ClN5O2 (297.09924659999996)
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile
2-AMINO-3-CARBAMOYL-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRIDINE-6-CARBOXYLIC ACID TERT-BUTYL ESTER
C13H19N3O3S (297.11470640000005)
4-(5-Formyl-thiazol-2-yl)-piperazine-1-carboxylic acid tert-butyl ester
C13H19N3O3S (297.11470640000005)
Teroxirone
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
Afegostat tartrate
C10H19NO9 (297.10597640000003)
C87006 - Pharmacological Chaperone
2-[[(E)-3-(4-methoxyphenyl)prop-2-enoyl]amino]benzoic acid
N,2-dimethyl-N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]furan-3-carboxamide
N-(3-nitrophenyl)-3,4-dihydro-1H-isoquinoline-2-carboxamide
(2s)-2-(4-Chlorophenyl)-2-[4-(1h-Pyrazol-4-Yl)phenyl]ethanamine
(2r)-2-(4-Chlorophenyl)-2-[4-(1h-Pyrazol-4-Yl)phenyl]ethanamine
3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-3H-pyrrolo[3,2-D]pyrimidin-7-YL)pyrrolidinium
C12H17N4O3S+ (297.10213120000003)
(E)-4-methyl-6-(3-methyl-1,4-dioxonaphthalen-2-yl)hex-4-enoate
2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-1H-purin-6-one
C11H15N5O5 (297.10731400000003)
2-[(2-hydroxy-3-methoxyphenyl)methylene]-N-(3-methoxypropyl)hydrazine-1-carbothioamide
C13H19N3O3S (297.11470640000005)
3-(2-Methoxy-6-methyl-3-pyridinyl)-5-(2-methoxyphenyl)-1,2,4-oxadiazole
4-(4-Chloro-2-methylphenoxy)-1-(4-morpholinyl)-1-butanone
8-(1H-indol-3-ylmethylidene)-6,10-dioxaspiro[4.5]decane-7,9-dione
3-(3-methoxyphenyl)-N-(3-pyridinyl)-4,5-dihydroisoxazole-5-carboxamide
1-(4-Methoxyphenyl)-3-(2-methyl-1,3-benzoxazol-5-yl)urea
(Z)-4-[3-(benzylamino)phenyl]-2-hydroxy-4-oxo-but-2-enoic acid
4-Amino-3-cyclohexylcarbamoyl-isothiazole-5-carboxylic acid ethyl ester
C13H19N3O3S (297.11470640000005)
Methyl 2-[(2-methoxyacetyl)amino]-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
C14H19NO4S (297.10347340000004)
methyl 2-[(butoxycarbonyl)amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate
C14H19NO4S (297.10347340000004)
1-[(6-chloro-2-imidazo[1,2-a]pyridinyl)methyl]-3,4-dihydro-2H-quinoline
2-(D-alanylamino)-N-[(1S)-1-hydroxy-3-mercaptopropyl]benzamide
C13H19N3O3S (297.11470640000005)
(5Z)-5-[(2E)-3-(phenylamino)prop-2-en-1-ylidene]-1-(prop-2-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione
Ethyl 2-cyano-3-[(6-methoxyquinolin-8-yl)amino]prop-2-enoate
4-[[6,7-Bis(hydroxymethyl)-4-quinazolinyl]amino]phenol
4-({[3,5-Dimethyl-4-(methylthio)phenoxy]carbonyl}amino)butanoic acid
C14H19NO4S (297.10347340000004)
3-[(Diethoxyphosphinyl)methyl]-5-phenyl-2-isoxazoline
N(2)-Methylguanosine
C11H15N5O5 (297.10731400000003)
Guanosine with the hydrogen on the amine at position N-2 substituted with a methyl group.
fusarithioamide A
C13H19N3O3S (297.11470640000005)
A member of the class of benzamides that is 2-aminobenzoic acid in which the hydrogen atom of the carboxy group has been substituted by a [(1S)-1-hydroxy-3-mercaptopropyl]nitrilo group and in which one of the the hydrogens of the amino group has been substituted by a (2R)-2-aminopropanoyl group. It is a metabolite isolated from the endophytic fungus, Fusarium chlamydosporium.
6-O-Methyl Guanosine
C11H15N5O5 (297.10731400000003)
6-O-Methyl Guanosine is a modified nucleoside[1]. 6-O-Methyl Guanosine (6-methylguanosine) inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line[2].
7-Methylguanosine
C11H15N5O5 (297.10731400000003)
7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor with IC50 value of 87.8?±?7.5?μM. 7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor with IC50 value of 87.8?±?7.5?μM.
4-{5-[(4-hydroxyphenyl)methyl]-1,2,4-triazol-1-yl}-3-methoxyphenol
3-(4-hydroxy-3,5-dimethoxybenzylidene)-2-indolinone
{"Ingredient_id": "HBIN007476","Ingredient_name": "3-(4-hydroxy-3,5-dimethoxybenzylidene)-2-indolinone","Alias": "NA","Ingredient_formula": "C17H15NO4","Ingredient_Smile": "NA","Ingredient_weight": "297.31","OB_score": "NA","CAS_id": "189098-75-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8488","PubChem_id": "NA","DrugBank_id": "NA"}
alpha-D-Arabinofuranosyladenine
C11H15N5O5 (297.10731400000003)
{"Ingredient_id": "HBIN015484","Ingredient_name": "alpha-D-Arabinofuranosyladenine","Alias": "(2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl-; (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 9-alpha-D-Arabinofuranosyladenine; NSC 70422; 6936-84-1; AIDS023910; NSC 40584; 9H-Purin-6-amine, 9-alpha-D-arabinofuranosyl- (9CI); (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl- (8CI); (2S,3S,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS-023910","Ingredient_formula": "C11H15N5O5","Ingredient_Smile": "C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N","Ingredient_weight": "297.27","OB_score": "20.89729146","CAS_id": "6936-84-1","SymMap_id": "SMIT12080","TCMID_id": "NA","TCMSP_id": "MOL011145","TCM_ID_id": "NA","PubChem_id": "96368","DrugBank_id": "NA"}
annocherine a
{"Ingredient_id": "HBIN016208","Ingredient_name": "annocherine a","Alias": "NA","Ingredient_formula": "C17H15NO4","Ingredient_Smile": "COC1=C(C=C2C(=C1)C=CN=C2C(C3=CC=C(C=C3)O)O)O","Ingredient_weight": "297.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1298","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "637078","DrugBank_id": "NA"}
3-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]-1h-indol-2-one
(2z,4z)-2-ethylidene-5-hydroxy-4-({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)pyrrol-3-one
(1r,4r,5s)-4-(2-chloroethyl)-1-(cyclohex-2-en-1-ylmethyl)-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one
(1r,4r,5s)-4-(2-chloroethyl)-1-[(1r)-cyclohex-2-en-1-ylmethyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one
(3ar,7as)-3a-hydroxy-1-[(2e)-3-phenylprop-2-enoyl]-7,7a-dihydro-3h-indole-2,6-dione
1-[(r)-hydroxy(4-hydroxyphenyl)methyl]-6-methoxyisoquinolin-7-ol
(1s,4r)-4,11'-dihydroxy-10'-methoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,4'(12'),5',7',9'-hexaen-3'-one
(2r,3r,4s,5r)-2-(6-amino-2-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
C11H15N5O5 (297.10731400000003)
4-hydroxy-12,17-dimethyl-13-oxa-16-azatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(17),3,5,7,10-pentaene-2,9-dione
(1s,4s)-4-hydroxy-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2'(6'),7',9',11'-pentaen-13'-one
(3e)-3-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]indol-2-ol
2-[6-hydroxy-2-(methylimino)-3h-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
C11H15N5O5 (297.10731400000003)